Read More: eGenesis Announces Second Patient Successfully Transplanted with Genetically Engineered Porcine Kidney
eGenesis Announces $125 Million Series C Financing
eGenesis Announces Research Collaboration with Leading Academic Medical Center
eGenesis Appoints Biotechnology Development Executive, Michael Curtis, Ph.D., as President of Research & Development
eGenesis Appoints Biopharmaceutical Executive, Peter Hanson, DVM, Ph.D., as Chief Operating Officer
eGenesis Expands Research Collaboration with Massachusetts General Hospital
eGenesis Strengthens Production Capabilities with Acquisition of ICBiotec
eGenesis Appoints David A. Carmel as Senior Vice President, Public Affairs and Communications
eGenesis Announces $100 Million Series B Financing
eGenesis Appoints Ariel Jasie as Chief Business Officer and General Counsel
eGenesis Appoints Paul Sekhri as President and Chief Executive Officer